Otomagnetics


Otomagnetics is developing a non-invasive magnetic drug delivery system aimed at delivering therapies to the inner and middle ear, eye, and skin. Their proprietary technology uses magnetic injection with biodegradable magnetic particles to treat various conditions, including hearing loss, tinnitus, middle ear infections, and eye diseases like macular degeneration. The company focuses on creating innovative, non-invasive solutions to address unmet medical needs across large markets.

Industries

biotechnology
delivery
health-care
medical
medical-device
pharmaceutical
staffing-agency

Nr. of Employees

small (1-50)

Otomagnetics

Bethesda, Maryland, United States, North America


Products

Magnetic injection delivery platform (device + biodegradable magnetic particles)

A platform combining a magnetic injector device with biodegradable magnetic particles formulated for injection. Designed to deliver therapeutic payloads non‑invasively to inner ear, middle ear, retinal and cutaneous targets in preclinical studies.


Services

Partnerships and collaborative development

Collaboration with pharmaceutical companies, advocacy groups, foundations and other organizations for co‑development, licensing or joint research related to magnetic nanoparticle delivery.

Expertise Areas

  • Non‑invasive targeted drug delivery
  • Nanoparticle formulation for injectable use
  • Preclinical development and animal‑model efficacy testing
  • Otic (inner and middle ear) therapeutics
  • Show More (4)

Key Technologies

  • Magnetic field‑directed targeting
  • Biodegradable magnetic nanoparticles
  • Magnetically guided injectable delivery
  • Payload loading for small molecules, proteins and genes
  • Show More (2)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.